Examkin

Question

Difficulty: Very hardGynecologic Infections

A 24-year-old woman, G1P0, at 14 weeks gestation presents to the emergency department with a 2-day history of worsening lower abdominal pain, chills, and a malodorous vaginal discharge. She has a history of asthma and a documented severe allergy to amoxicillin, which caused anaphylaxis and required intubation during childhood. Her temperature is 38.8°C (101.8°F), blood pressure is 112/70 mm Hg, and pulse is 110/min. Physical examination reveals a friable cervix with purulent exudate. Bimanual examination demonstrates exquisite cervical motion tenderness and bilateral adnexal tenderness without palpable masses. Transabdominal ultrasound confirms a viable intrauterine gestation with a normal fetal heart rate and no adnexal fluid collections. Which of the following is the most appropriate next step in management?

  1. A
    Admission for intravenous cefoxitin and oral doxycycline
  2. B
    Outpatient management with intramuscular ceftriaxone and oral azithromycin
  3. C
    Outpatient management with oral levofloxacin and oral metronidazole
  4. Admission for intravenous clindamycin and intravenous gentamicinAnswer
  5. E
    Admission for intravenous ceftriaxone and oral azithromycin

Answer

Admission for intravenous clindamycin and intravenous gentamicin
This patient has acute Pelvic Inflammatory Disease (PID) complicated by pregnancy. Pregnant patients with PID must be admitted to the hospital for intravenous antibiotics due to the high risks of maternal morbidity and adverse pregnancy outcomes (such as preterm delivery and fetal loss). When selecting a regimen, teratogenic drugs commonly used for PID, such as doxycycline (risk of fetal bone/tooth discoloration) and fluoroquinolones (risk of cartilage damage), are contraindicated. Additionally, this patient has a history of severe anaphylaxis to amoxicillin (a penicillin). This strong allergic reaction dictates the avoidance of other beta-lactam antibiotics, including cephalosporins like cefoxitin or ceftriaxone, due to the risk of cross-reactivity. The regimen of intravenous clindamycin and gentamicin provides excellent broad-spectrum and anaerobic coverage for PID, avoids teratogens, and contains no beta-lactam rings, making it the safest and most appropriate choice.

Step-by-Step Solution

1
Diagnose the primary condition based on the clinical presentation.
The patient has fever, lower abdominal pain, cervical motion tenderness, and purulent discharge, which establishes the diagnosis of acute pelvic inflammatory disease (PID).
Recognizing the classic signs of PID is the first step in formulating a management plan.
2
Evaluate the patient's pregnancy status to determine the appropriate treatment setting.
The patient is 14 weeks pregnant. Therefore, she requires inpatient admission for parenteral antibiotic therapy.
PID during pregnancy carries a high risk of maternal morbidity, preterm labor, and fetal loss, making outpatient management unsafe.
3
Review the patient's allergies and pregnancy status to select safe pharmacotherapy.
Doxycycline and fluoroquinolones must be avoided due to pregnancy. Beta-lactam antibiotics (including cephalosporins like cefoxitin and ceftriaxone) must be avoided due to a history of severe penicillin anaphylaxis.
Preventing teratogenic effects and life-threatening allergic reactions is critical when selecting an antimicrobial regimen.
4
Identify the standard alternative parenteral regimen that accommodates all constraints.
Intravenous clindamycin combined with intravenous gentamicin is selected.
This regimen provides the necessary broad-spectrum coverage for PID, avoids teratogens, and is free of beta-lactam components.

Key Concept

Management of Pelvic Inflammatory Disease in pregnancy requires inpatient admission and avoidance of both teratogenic antibiotics (doxycycline, fluoroquinolones) and any drug classes contraindicated by the patient's specific severe allergies (e.g., avoiding cephalosporins in severe penicillin anaphylaxis).
Estimated Time:2m 0s
Rate this question

Topics

Gynecologic Infections

More questions from this topic